Evidence map›Paper›PMID 39720555›Full record

ArticleFrontiers in chemistry2024

Phytochemical profiling and fractionation of

Ibtissam Laib, Djahra Ali Boutlilis, Huda Alsaeedi, David Cornu, Mikhael Bechelany, Ahmed Barhoum

Abstract read
In one paragraph

Article in Frontiers in chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ibtissam LaibDepartment of Cellular and Molecular Biology, El Oued University, El Oued, Algeria.
Djahra Ali BoutlilisDepartment of Cellular and Molecular Biology, El Oued University, El Oued, Algeria.
Huda AlsaeediDepartment of Chemistry, College of Science, King Saud University, Riyadh, Saudi Arabia.
David CornuInstitut Européen des Membranes, IEM, University Montpellier, ENSCM, CNRS, Montpellier, France.
Mikhael BechelanyInstitut Européen des Membranes, IEM, University Montpellier, ENSCM, CNRS, Montpellier, France.
Ahmed BarhoumChemistry Department, NanoStruc Research Group, Faculty of Science, Helwan University, Cairo, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: This study investigates the synthesis of silver nanoparticles (Ag NPs) using Helianthemum lippii extract and evaluates their photoprotective, anti-hemolytic, antibacterial, and anti-inflammatory properties compared to various extract fractions, including total aqueous extract (AE), flavonoid monoglycosides (FMG), flavonoid diglycosides/triglycosides (FDG/FTG), tannins (TN), and anthocyanins (AC). Helianthemum lippii is rich in bioactive compounds such as caffeic acid, p-coumaric acid, and gallic acid, known for their therapeutic potential. This study aims to determine whether embedding these phytochemicals into Ag NPs enhances their biomedical applications compared to the natural extract fractions. Methods: Ag NPs were synthesized using Results: HPLC analysis confirmed the presence of bioactive compounds, including caffeic acid, p-coumaric acid, and gallic acid, in the AE extract. The Ag NPs were spherical with an average diameter of 35 nm and had phytochemicals adsorbed on their surface. The AC fraction demonstrated the highest SPF (28.27), followed by TN (27.99), AE (23.20), and Ag NPs (22.50), while FMG exhibited a moderate SPF (19.39) compared to the commercial sunscreen Avene Discussion: The findings demonstrate that Helianthemum lippii-derived Ag NPs exhibit enhanced antibacterial, anti-inflammatory, and anti-hemolytic properties compared to the extract fractions. While the SPF of Ag NPs was slightly lower than the AC and TN fractions, their superior multifunctional bioactivities underscore their potential for various biomedical applications. The integration of phytochemicals into Ag NPs significantly enhances their therapeutic efficacy, making them promising candidates for advanced pharmaceutical formulations and topical protective agents.

Indexed as

anti-bacterial activityanti-hemolytic activityanti-inflammatory propertiesbioactive fractionsbiomedical applicationsgreen synthesisHelianthemum lippii

Identifiers

PMID39720555
PMCPMC11666390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.